Showing results (361-370 of 2,355) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|April 1, 1992
Action of nimodipine on sympathomimetic mydriatics in humansM Alessandri, U Pietrini, E B Bandini, et al.Clinical Neuropharmacology|August 21, 2004
Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosisLetterio Morgante, Antonio Epifanio, Edoardo Spina, et al.Clinical Neuropharmacology|August 21, 2004
A case of prolonged seizure activity after combined use of bupropion and clomipramineYong-Wook Shin, Tae Moon Erm, Eun Jung Choi, et al.Clinical Neuropharmacology|August 3, 2005
Quetiapine for insomnia in Parkinson disease: results from an open-label trialCarlos Juri, Pedro Chaná, John Tapia, et al.Clinical Neuropharmacology|August 3, 2005
Remarkable effect of selegiline (L-deprenyl), a selective monoamine oxidase type-B inhibitor, in a patient with severe refractory depression: a case reportHisashi Higuchi, Mitsuhiro Kamata, Yuka Sugawara, et al.Clinical Neuropharmacology|August 3, 2005
Neuropsychiatric sequelae of neuroleptic malignant syndromeAdityanjee, Martha Sajatovic, Kaizad R MunshiClinical Neuropharmacology|August 3, 2005
Topiramate as an adjuvant treatment with atypical antipsychotics in schizophrenic patients experiencing weight gainYoung-Hoon Ko, Sook-Haeng Joe, In-Kwa Jung, et al.Clinical Neuropharmacology|August 3, 2005
Efficacy and tolerability of low-dose donepezil in schizophreniaSteven K Erickson, Steven B Schwarzkopf, Donna Palumbo, et al.Clinical Neuropharmacology|March 7, 2006
Response rate obtained using milnacipran depending on the severity of depression in the treatment of major depressive patientsYuka Sugawara, Hisashi Higuchi, Keizo Yoshida, et al.Clinical Neuropharmacology|March 7, 2006
The anti-dementia drugs: myth, hype or reality?Hervé Allain, Allain Hervé, Danièle Bentué-FerrerPageof 236